These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30450675)

  • 1. Characterization of aged rat vocal fold fibroblasts.
    Kawai Y; Kishimoto Y; Sogami T; Suzuki R; Tsuji T; Hiwatashi N; Tateya I; Kanemaru SI; Nakamura T; Omori K; Hirano S
    Laryngoscope; 2019 Mar; 129(3):E94-E101. PubMed ID: 30450675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryotherapy has antifibrotic and regenerative effects on human vocal fold fibroblasts.
    Gong T; Zhang C; Kang J; Lamb JJ; Jiang JJ
    Laryngoscope; 2019 Apr; 129(4):E143-E150. PubMed ID: 30315572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HGF and bFGF Secreted by Adipose-Derived Mesenchymal Stem Cells Revert the Fibroblast Phenotype Caused by Vocal Fold Injury in a Rat Model.
    Li X; Wang H; Xu W
    J Voice; 2022 Sep; 36(5):622-629. PubMed ID: 32921552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling fibrosis using fibroblasts isolated from scarred rat vocal folds.
    Kishimoto Y; Kishimoto AO; Ye S; Kendziorski C; Welham NV
    Lab Invest; 2016 Jul; 96(7):807-16. PubMed ID: 27111284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of basic fibroblast growth factor on rat vocal fold fibroblasts.
    Suehiro A; Hirano S; Kishimoto Y; Tateya I; Rousseau B; Ito J
    Ann Otol Rhinol Laryngol; 2010 Oct; 119(10):690-6. PubMed ID: 21049855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of a novel collagen-gelatin scaffold with basic fibroblast growth factor for the treatment of vocal fold scar.
    Hiwatashi N; Hirano S; Mizuta M; Kobayashi T; Kawai Y; Kanemaru SI; Nakamura T; Ito J; Kawai K; Suzuki S
    J Tissue Eng Regen Med; 2017 May; 11(5):1598-1609. PubMed ID: 26119035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient Receptor Potential Ankyrin 1 Channel Alters Transforming Growth Factor Beta 1/Smad Signaling in Rat Vocal Fold Fibroblasts.
    Matsushita H; Mukudai S; Hashimoto K; Kaneko M; Sugiyama Y; Branski RC; Hirano S
    Laryngoscope; 2024 Nov; 134(11):4593-4598. PubMed ID: 38860441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NR4A1 is an endogenous inhibitor of vocal fold fibrosis.
    Hiwatashi N; Bing R; Kraja I; Branski RC
    Laryngoscope; 2017 Sep; 127(9):E317-E323. PubMed ID: 28581197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of hepatocyte growth factor and interleukin-6 on transforming growth factor-beta1 mediated vocal fold fibroblast-myofibroblast differentiation.
    Vyas B; Ishikawa K; Duflo S; Chen X; Thibeault SL
    Ann Otol Rhinol Laryngol; 2010 May; 119(5):350-7. PubMed ID: 20524582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vocal fold fibroblast response to growth factor treatment is age dependent: results from an in vitro study.
    Graupp M; Kiesler K; Friedrich G; Ainödhofer H; Gruber HJ; Kieslinger P; Saxena A; Hirano S; Gugatschka M
    J Voice; 2014 Jul; 28(4):420-3. PubMed ID: 24495429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of growth factors for aging voice.
    Hirano S; Bless DM; del Río AM; Connor NP; Ford CN
    Laryngoscope; 2004 Dec; 114(12):2161-7. PubMed ID: 15564837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms Underlying the Antifibrotic Potential of Estradiol for Vocal Fold Fibrosis.
    Ozawa S; Mukudai S; Sugiyama Y; Branski RC; Hirano S
    Laryngoscope; 2021 Oct; 131(10):2285-2291. PubMed ID: 33378560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells have antifibrotic effects on transforming growth factor-β1-stimulated vocal fold fibroblasts.
    Hiwatashi N; Bing R; Kraja I; Branski RC
    Laryngoscope; 2017 Jan; 127(1):E35-E41. PubMed ID: 27345475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling.
    Shinde AV; Humeres C; Frangogiannis NG
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):298-309. PubMed ID: 27825850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual growth factor-immobilized bioactive injection material for enhanced treatment of glottal insufficiency.
    Choi YH; Ahn HJ; Park MR; Han MJ; Lee JH; Kwon SK
    Acta Biomater; 2019 Mar; 86():269-279. PubMed ID: 30599245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of hepatocyte growth factor and transforming growth factor beta1 in production of extracellular matrix by canine vocal fold fibroblasts.
    Hirano S; Bless D; Heisey D; Ford C
    Laryngoscope; 2003 Jan; 113(1):144-8. PubMed ID: 12514399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regenerative effects of basic fibroblast growth factor on extracellular matrix production in aged rat vocal folds.
    Ohno T; Yoo MJ; Swanson ER; Hirano S; Ossoff RH; Rousseau B
    Ann Otol Rhinol Laryngol; 2009 Aug; 118(8):559-64. PubMed ID: 19746753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular source and proinflammatory roles of high-mobility group box 1 in surgically injured rat vocal folds.
    Li-Jessen NYK; Powell M; Choi AJ; Lee BJ; Thibeault SL
    Laryngoscope; 2017 Jun; 127(6):E193-E200. PubMed ID: 27774594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility and efficacy of collagen/gelatin sponge scaffold with sustained release of basic fibroblast growth factor on vocal fold fibroblasts in 3-dimensional culture.
    Hiwatashi N; Hirano S; Mizuta M; Tateya I; Kanemaru S; Nakamura T; Ito J; Kawai K; Suzuki S
    Ann Otol Rhinol Laryngol; 2015 Feb; 124(2):116-25. PubMed ID: 25115594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human vocal fold fibroblasts derived from chronic scar.
    Jetté ME; Hayer SD; Thibeault SL
    Laryngoscope; 2013 Mar; 123(3):738-45. PubMed ID: 23444190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.